Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Sotalol products are in shortage in Canada (3 of 12 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Dec 1, 2026.
A beta blocker used to treat and prevent abnormal heart rhythms.
Products affected
3 / 12
In shortage since
Dec 1, 2019
Est. full return
Dec 1, 2026
Reports on file
36
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
PMS-SOTALOL - 160 MG
160MG · TABLET · PHARMASCIENCE INC
DIN 02238327 · since Sep 3, 2024, est. end Dec 1, 2026 · Disruption of the manufacture of the drug.
Active shortage
JAMP-SOTALOL
160MG · TABLET · JAMP PHARMA CORPORATION
DIN 02368625 · since Feb 9, 2022, est. end Dec 31, 2023 · Disruption of the manufacture of the drug.
Active shortage
JAMP-SOTALOL
80MG · TABLET · JAMP PHARMA CORPORATION
DIN 02368617 · since Dec 1, 2019, est. end Dec 30, 2022 · Disruption of the manufacture of the drug.
Resolved
APO-SOTALOL
80MG · TABLET · APOTEX INC
DIN 02210428 · ended Nov 20, 2025 · Disruption of the manufacture of the drug.
reversed
PMS-SOTALOL - 160 MG
160MG · TABLET · PHARMASCIENCE INC
DIN 02238327
Resolved
APO-SOTALOL
160MG · TABLET · APOTEX INC
DIN 02167794 · ended Jan 18, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-SOTALOL
160MG · TABLET · APOTEX INC
DIN 02167794 · ended Jan 4, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-SOTALOL
160MG · TABLET · APOTEX INC
DIN 02167794 · ended Jun 23, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-SOTALOL
80MG · TABLET · APOTEX INC
DIN 02210428 · ended Jun 23, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-SOTALOL
160MG · TABLET · APOTEX INC
DIN 02167794 · ended Feb 14, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-SOTALOL
80MG · TABLET · APOTEX INC
DIN 02210428 · ended Feb 14, 2023 · Disruption of the manufacture of the drug.
Resolved
APO-SOTALOL 80MG TABLETS
80MG · TABLET · APOTEX INC
DIN 02210428 · ended Jul 14, 2022 · Disruption of the manufacture of the drug.
Showing 12 of 36 reports. All reports are on file with Health Canada.
What's happening
Sotalol is currently affected by 3 active shortage reports filed with Health Canada by PHARMASCIENCE INC, JAMP PHARMA CORPORATION.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Sotalol is classified under “BETA BLOCKING AGENTS” (ATC C07AA).
Recent changes
No changes recorded yet.
Common questions
What is Sotalol used for?
A beta blocker used to treat and prevent abnormal heart rhythms.
When will Sotalol be back in stock in Canada?
The latest manufacturer estimate is Dec 1, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Sotalol in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.